Here, we identify MCJ (Methylation-Controlled J protein) as a target for non-alcoholic steatohepatitis (NASH), an advanced phase of NAFLD. The gene discussed is DNAJC15; the disease is metabolic dysfunction-associated steatotic liver disease.